Motoi S.B. 1, Bîrsăsteanu F. 1, Mogoseanu Maria 1, Costachescu D. 2, Cerbu Simona 3, Gafencu M. 1
1 Victor Babes University of Medicine and Pharmacy Timisoara
2 Department of Radiology County Hospital Timisoara
3 Telescan Imaging Center Timisoara
Abstract
The MRI is “the gold standard” to evaluate the nodular liver. A study made over a period of 22 months between 2009 and 2011 assessed the side effects of 2 types of contrast agents (SPIO and gadobutrol) administered to patients that underwent MRI investigations aimed to diagnose hepatic nodular lesions. 134 patients were examined and monitored. Gadolinium MRI contrast agents are much safer than the contrast used on CT, anaphylactic reactions being rare. None of the patients developed any clinical or biological side effects, contrast agents for magnetic resonance imaging being much safer than contrast used in computer tomography. Sex, age or associated pathology of the patients don’t represent risk factors for the development of adverse reactions.